Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting

    Flow-cytometric detection of minimal residual disease (MRD) has proven in several single-institute studies to have an independent prognostic impact. We studied whether this relatively complex approach could be...

    N Feller, V H J van der Velden, R A Brooimans, N Boeckx, F Preijers in Blood Cancer Journal (2013)

  2. No Access

    Article

    Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

    Acute myeloid leukemia (AML) is generally regarded as a stem cell disease. In CD34-positive AML, the leukemic stem cell has been recognized as CD38 negative. This CD34+CD38− population survives chemotherapy an...

    A van Rhenen, B Moshaver, A Kelder, N Feller, A W M Nieuwint, S Zweegman in Leukemia (2007)

  3. No Access

    Article

    MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

    Outgrowth of minimal residual disease (MRD) in acute myeloid leukaemia (AML) is responsible for the occurrence of relapses. MRD can be quantified by immunophenoty** on a flow cytometer using the expression o...

    N Feller, M A van der Pol, A van Stijn, G W D Weijers, A H Westra, B W Evertse in Leukemia (2004)

  4. No Access

    Article

    Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile

    A van Stijn, A Kok, M A van Stalborch, M A van der Pol, N Feller, A H Westra in Leukemia (2004)

  5. No Access

    Article

    Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis

    M A van der Pol, N Feller, G J Ossenkoppele, G W D Weijers, A H Westra in Leukemia (2003)

  6. No Access

    Article

    Multiparameter flow cytometric quantification of apoptosis-related protein expression

    A van Stijn, A Kok, M A van der Pol, N Feller, G M J M Roemen, A H Westra in Leukemia (2003)

  7. No Access

    Article

    A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia

    Minimal residual disease (MRD) cells are thought to be responsible for the persistence and relapse of acute myeloid leukemia (AML). Flow cytometric MRD detection by the establishment of a leukemia-associated p...

    A van Stijn, A Kok, M A van der Pol, N Feller, G M J M Roemen, A H Westra in Leukemia (2003)

  8. No Access

    Article

    High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

    In this study, a high CD34% in autologous peripheral blood stem cell (PBSC) products from 71 AML patients was associated directly with a high relapse rate (P = 0.006) and inversely with disease-free survival (P =...

    N Feller, G J Schuurhuis, M A van der Pol, G Westra, G W D Weijers, A van Stijn in Leukemia (2003)

  9. No Access

    Article

    Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia

    Relapse is common in acute myeloid leukemia (AML) due to persistence of residual leukemia cells: minimal residual disease (MRD). In 102 out of 127 patients (80%), cells at diagnosis displayed one or more leuke...

    MA van der Pol, JM Pater, N Feller, AH Westra, A van Stijn, GJ Ossenkoppele in Leukemia (2001)

  10. No Access

    Article

    Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry

    Multidrug resistance (MDR) in tumour cells is often caused by the overexpression of the plasma membrane drug transporter P-glycoprotein (P-gp) or the recently discovered multidrug resistance-associated protein...

    N Feller, CM Kuiper, J Lankelma, JK Ruhdal, RJ Scheper in British Journal of Cancer (1995)

  11. No Access

    Article

    Cortisol is transported by the multidrug resistance gene product P-glycoprotein

    The physiology of the multidrug transporter P-glycoprotein (Pgp) is still poorly understood. We now show evidence that cell lines with a high expression of Pgp display a reduced accumulation of cortisol and an...

    CK van Kalken, HJ Broxterman, HM Pinedo, N Feller, H Dekker in British Journal of Cancer (1993)

  12. No Access

    Article

    Prenatal diagnosis of systemic disorders of the respiratory chain in cultured amniocytes and chorionic villus fibroblasts by studying the formation of lactate and pyruvate from glucose

    Formation of lactate and pyruvate from glucose was studied in cultured amniocytes and chorionic villus fibroblasts from controls, either untreated or treated with azide, an inhibitor of cytochromec oxidase, or ot...

    R. J. A. Wanders, F. A. Wijburg, J. Ruiter in Journal of Inherited Metabolic Disease (1992)

  13. No Access

    Article

    Restoration of NADH-oxidation in complex I and complex III deficient fibroblasts by menadione

    F. A. Wijburg, C. J. de Groot, N. Feller in Journal of Inherited Metabolic Disease (1991)

  14. No Access

    Article

    Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

    Bridget T. Hill, L. K. Hosking, S. McClean in Journal of Cancer Research and Clinical On… (1991)

  15. No Access

    Article

    Detection of respiratory chain dysfunction by measuring lactate and pyruvate production in cultured fibroblasts

    F. A. Wijburg, N. Feller, W. Ruitenbeek in Journal of Inherited Metabolic Disease (1990)

  16. No Access

    Article

    First prenatal diagnosis of acyl-CoA oxidase deficiency

    R. J. A. Wanders, A. Schelen, N. Feller in Journal of Inherited Metabolic Disease (1990)

  17. No Access

    Article

    Lactate dehydrogenase and alkaline phosphatase isoenzymes and protein-bound sialic acid in regenerating rat liver

    Lactate dehydrogenase (LDH) and alkaline phosphatase (AP) isoenzyme patterns and protein-bound sialic acid content were compared between normal, regenerating rat liver 10 days after partial hepatectomy and fet...

    D. Allalouf, S. Schwarzman, H. Levinsky, N. Feller in Research in Experimental Medicine (1986)

  18. No Access

    Article

    Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients

    Prostaglandin E2 and cyclic AMP (cAMP) levels were measured in tumors and plasma of 78 patients with benign and malignant breast tumors. Two groups of malignant tissues were found, one with a high level of PGE2 M...

    T. Malachi, Ch. Chaimoff, N. Feller in Journal of Cancer Research and Clinical On… (1981)

  19. No Access

    Article

    Enzyme activities in regenerating liver of rats

    The activities of eight enzymes were determined in the regenerating liver of rats after partial hepatectomy. For five enzymes, i.e., aldolase, lactate dehydrogenase, alanine transaminase, 5-nucleotidase, and a...

    R. Menache, N. Feller, I. Halbrecht, M. Djaldetti in Research in Experimental Medicine (1980)

  20. No Access

    Article

    Prostaglandin E2 and cyclic AMP levels in human breast tumors

    Prostaglandin E2 (PGE2) and cyclic adenosine-3′, 5′-monophosphate (cAMP) concentrations were measured in human benign and malignant breast tumors by radioimmunoassay. Two groups were found among the malignant tis...

    N. Feller, T. Malachi, I. Halbrecht in Journal of Cancer Research and Clinical Oncology (1979)

previous disabled Page of 2